Kühne Thomas, Blanchette Victor, Buchanan George R, Ramenghi Ugo, Donato Hugo, Tamminga Rienk Y J, Rischewski Johannes, Berchtold Willi, Imbach Paul
University Children's Hospital, Basel, Switzerland.
Pediatr Blood Cancer. 2007 Nov;49(6):829-34. doi: 10.1002/pbc.21108.
Splenectomy is an effective procedure for children and adults with severe or refractory idiopathic thrombocytopenic purpura (ITP). Data regarding pediatric patients are limited.
Sixty-eight Intercontinental Childhood ITP Study Group (ICIS) investigators from 57 institutions in 25 countries participated in a splenectomy registry. Data from 153 patients were submitted, of whom 134 had a splenectomy and were analyzed.
The median age at splenectomy was 11.8 (2.7-20.7) years. The median postsplenectomy follow-up was 2.0 (0.1-4.5) years. Pre-splenectomy vaccination was not administered in 21 children (15.7%). Open and laparoscopic splenectomy procedures were performed in 67 and 65 evaluable children, respectively. Surgical technique was not reported in two children. Overall immediate platelet response to splenectomy was achieved in 113 patients (86.3%). Eighty percent of responders maintained their status of response during the following 4 years. Older age, longer duration of ITP, and male gender correlated with a complete response. Post-splenectomy sepsis was reported in seven patients without lethal outcome, although sepsis might be differently defined at participating institutions.
Splenectomy is effective in children with ITP. Management varies greatly in different institutions. These Registry data may serve as a basis for future clinical trials to assess the indication and timing of splenectomy.
脾切除术对于患有严重或难治性特发性血小板减少性紫癜(ITP)的儿童和成人是一种有效的治疗方法。关于儿科患者的数据有限。
来自25个国家57个机构的68名洲际儿童ITP研究组(ICIS)研究人员参与了一项脾切除术登记研究。提交了153例患者的数据,其中134例接受了脾切除术并进行了分析。
脾切除术时的中位年龄为11.8(2.7 - 20.7)岁。脾切除术后的中位随访时间为2.0(0.1 - 4.5)年。21名儿童(15.7%)未在脾切除术前进行疫苗接种。分别有67例和65例可评估儿童接受了开放和腹腔镜脾切除术。有2名儿童未报告手术技术。113例患者(86.3%)术后立即出现血小板反应。80%的反应者在接下来的4年中维持了反应状态。年龄较大、ITP病程较长和男性与完全反应相关。7例患者报告了脾切除术后败血症,无致命结局,尽管参与机构对败血症的定义可能不同。
脾切除术对儿童ITP有效。不同机构的管理差异很大。这些登记研究数据可作为未来评估脾切除术适应证和时机的临床试验的基础。